These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Chang SH; Ai Y; Breyer RM; Lane TF; Hla T Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin. Ansari KM; Sung YM; He G; Fischer SM Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233 [TBL] [Abstract][Full Text] [Related]
5. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Sung YM; He G; Fischer SM Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392 [TBL] [Abstract][Full Text] [Related]
6. Structure-function analyses of eicosanoid receptors. Physiologic and therapeutic implications. Breyer RM; Kennedy CR; Zhang Y; Breyer MD Ann N Y Acad Sci; 2000 Apr; 905():221-31. PubMed ID: 10818456 [TBL] [Abstract][Full Text] [Related]
7. Effects of prostanoid EP agonists on mouse intraocular pressure. Saeki T; Ota T; Aihara M; Araie M Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925 [TBL] [Abstract][Full Text] [Related]
9. Association between prostaglandin E2 receptor gene and essential hypertension. Sato M; Nakayama T; Soma M; Aoi N; Kosuge K; Haketa A; Izumi Y; Matsumoto K; Sato N; Kokubun S Prostaglandins Leukot Essent Fatty Acids; 2007 Jul; 77(1):15-20. PubMed ID: 17644362 [TBL] [Abstract][Full Text] [Related]
10. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. Reinold H; Ahmadi S; Depner UB; Layh B; Heindl C; Hamza M; Pahl A; Brune K; Narumiya S; Müller U; Zeilhofer HU J Clin Invest; 2005 Mar; 115(3):673-9. PubMed ID: 15719070 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy. Yuhki K; Ueno A; Naraba H; Kojima F; Ushikubi F; Narumiya S; Oh-ishi S J Pharmacol Exp Ther; 2004 Dec; 311(3):1218-24. PubMed ID: 15316088 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice. Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Sung YM; He G; Hwang DH; Fischer SM Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275 [TBL] [Abstract][Full Text] [Related]
14. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice. Popp L; Häussler A; Olliges A; Nüsing R; Narumiya S; Geisslinger G; Tegeder I Eur J Pain; 2009 Aug; 13(7):691-703. PubMed ID: 18938093 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. Zahner G; Schaper M; Panzer U; Kluger M; Stahl RA; Thaiss F; Schneider A Biochem J; 2009 Aug; 422(3):563-70. PubMed ID: 19570035 [TBL] [Abstract][Full Text] [Related]
16. The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Ota T; Aihara M; Saeki T; Narumiya S; Araie M Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3395-9. PubMed ID: 16877408 [TBL] [Abstract][Full Text] [Related]
17. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709 [TBL] [Abstract][Full Text] [Related]
18. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Hizaki H; Segi E; Sugimoto Y; Hirose M; Saji T; Ushikubi F; Matsuoka T; Noda Y; Tanaka T; Yoshida N; Narumiya S; Ichikawa A Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10501-6. PubMed ID: 10468638 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. Nomi T; Sho M; Akahori T; Kanehiro H; Nakajima Y Transplant Proc; 2006 Dec; 38(10):3209-10. PubMed ID: 17175225 [TBL] [Abstract][Full Text] [Related]
20. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes. Zhan P; Alander C; Kaneko H; Pilbeam CC; Guan Y; Zhang Y; Breyer MD; Raisz LG Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):19-26. PubMed ID: 16303601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]